What is the recommended hepatitis B vaccine dosing schedule for adults and infants, including accelerated and alternative regimens?

Hepatitis B Vaccine Dosing and Schedule

For adults aged 19-59 years, use the standard 3-dose schedule (0,1,6 months) with Recombivax HB (10 μg), Engerix-B (20 μg), or PreHevbrio (10 μg), or the convenient 2-dose Heplisav-B schedule (0,1 month); for infants, administer the birth dose within 24 hours followed by completion at 1-2 and 6-18 months. 1

Adult Vaccination (≥18 years)

Standard Regimens

Multiple vaccine options exist with varying schedules:

• Heplisav-B (≥18 years): 20 μg at 0 and 1 month - the most convenient 2-dose option 1
• Recombivax HB (≥20 years): 10 μg at 0,1, and 6 months 1
• Engerix-B (≥20 years): 20 μg at 0,1, and 6 months 1, 2
• PreHevbrio (≥18 years): 10 μg at 0,1, and 6 months (ACIP-recommended 2022) 1
• Twinrix (≥18 years): 20 μg HepB component at 0,1, and 6 months (standard) 1

Accelerated Regimen

For urgent protection needs (recent exposure, imminent travel to endemic areas):

• Twinrix accelerated: 4 doses at 0 days, 7 days, 21-30 days, and 12 months 1
• Engerix-B alternate: 0,1,2, and 12 months 2

The accelerated schedule provides faster initial protection but requires a 12-month booster for sustained immunity 2. While research shows lower antibody titers with accelerated schedules compared to standard regimens, seroprotection rates remain acceptable (>90%) 3, 4.

Special Populations - Adults

Hemodialysis and immunocompromised patients (≥20 years):

• Recombivax HB: 40 μg (4x standard dose) at 0,1, and 6 months 1
• Engerix-B: 40 μg (2 mL or two 1-mL injections) at 0,1,2, and 6 months (4-dose series) 1, 2
• Do NOT use Heplisav-B or PreHevbrio - safety and effectiveness not established in hemodialysis patients 1

Pregnant women:

• Use only Engerix-B, Recombivax HB, or Twinrix 1
• Avoid Heplisav-B and PreHevbrio due to insufficient pregnancy safety data 1

Annual antibody testing recommended for hemodialysis patients; give 40 μg booster when anti-HBs falls below 10 mIU/mL 2

Pediatric and Adolescent Vaccination

Infants (Birth through 10 years)

Birth dose (within 24 hours):

• 10 μg (0.5 mL) single-antigen vaccine - critical for preventing perinatal transmission 5, 6
• Serves as "safety net" for infants of unidentified HBsAg-positive mothers 5
• Associated with higher series completion rates 5

Complete series:

• Doses at 1-2 months and 6-18 months (10 μg each) 5, 2
• Alternative: 0,1,2,12 months for high-risk infants 2

The birth dose has demonstrated 99% reduction in pediatric HBV infections and strong safety profile over decades of use 6. Recent evidence confirms no improved safety or effectiveness with delayed first dose 6.

Adolescents (11-19 years)

Standard options:

• Ages 11-15: Recombivax HB 10 μg in 2-dose schedule at 0 and 4-6 months (adolescent-specific regimen) 1
  • If person turns 16 before second dose, switch to 3-dose series 1
• Ages 11-19: Standard 3-dose schedule (10 μg at 0,1,6 months) 1
• Ages 11-19: Alternative 20 μg adult formulation at 0,1,6 months 2

Extended schedule option:

• 0,12,24 months produces equivalent seroprotection (>98%) with high antibody titers, though slightly lower than 0,1,6 month schedule 7
• Useful when immediate exposure risk is low and compliance with standard schedule is challenging 7

Critical Scheduling Rules

If series interrupted (applies to all 3-dose schedules):

• Do NOT restart the series 1
• Minimum intervals: 4 weeks between doses 1-2; 8 weeks between doses 2-3; 16 weeks between doses 1-3 1
• Give delayed doses as soon as possible 1
• Doses given ≤4 days before minimum interval are valid 1

Exception: The 4-day grace period does NOT apply to first 3 doses of Twinrix accelerated schedule (0,7,21-30 days) 1

Administration Technique

Route and site:

• Intramuscular injection - deltoid in adults, anterolateral thigh in infants/young children 2
• Never gluteal injection - results in suboptimal response 2
• Subcutaneous acceptable only for bleeding disorder patients (lower GMTs expected) 2

Needle selection:

• Infants <12 months: 1-inch, 23-gauge (anterolateral thigh) 2
• Children ≤10 years: 5/8-inch, 25-gauge (deltoid) 2
• Older children/adults: 1-inch, 23-gauge 2

Common Pitfalls

1. Avoid gluteal injection - consistently produces inadequate immune response 2
2. Don't delay birth dose - eliminates critical protection window for perinatal transmission 5, 6
3. Don't use Heplisav-B or PreHevbrio in pregnancy or hemodialysis - insufficient safety data 1
4. Don't restart interrupted series - wastes doses and delays completion 1
5. Don't use combination vaccines (Comvax, Pediarix) for birth dose - only single-antigen vaccine approved for infants <6 weeks 5
6. Hemodialysis patients need higher doses and monitoring - standard doses produce inadequate response 2

Prevaccination Testing

Testing is optional, not required 1:

• Consider for those with high likelihood of prior infection or immunity
• Test for HBsAg, anti-HBs, and anti-HBc (triple panel) 1
• Lack of testing access should never delay vaccination 1

Post-vaccination serology has no role in routine clinical decision-making for completing the vaccine series 6